GGrantIndex
Sort

17,828 grants matching crispr

CRX AND ITS REGULATORY NETWORK IN RETINAL DEGENERATIONS

$518,466
Shiming Chen · Washington University · R01 · FY2020 · EY

Cell Biology of Reovirus Infection

$518,440
Terence S. Dermody · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI

Targeting the orphan nuclear receptor LRH-1 with small molecules

$518,408
Eric A Ortlund · Emory University · R01 · FY2024 · DK

NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer

$518,399
Dan Theodorescu · Cedars-Sinai Medical Center · R01 · FY2022 · CA

Critical Lipid Species in the Hepatovirus Lifecycle

$518,380
Stanley M Lemon · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AI

Identifying Cis-Regulatory Variants, Genes, and Regulatory Networks Underlying QT Interval Variation

$518,231
Ashish Kapoor · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · HL

Characterization of enzymes in the vitamin K cycle

$518,106
Jianke Tie · Univ Of North Carolina Chapel Hill · R01 · FY2022 · HL

Extrachromosomal DNA as a Targetable Mechanism in Glioblastoma

$518,051
Roel Gw Verhaak · Jackson Laboratory · R01 · FY2021 · CA

Extrachromosomal DNA as a Targetable Mechanism in Glioblastoma

$518,051
Roel Gw Verhaak · Jackson Laboratory · R01 · FY2020 · CA

Clonal Therapy for Pediatric T-cell Acute Lymphoblastic Leukemia

$518,050
Jiyang Yu · St. Jude Children'S Research Hospital · U01 · FY2023 · CA

Functional Analysis of Variants Underlying T Cell Defects

$518,030
David L Wiest · University Of California, San Francisco · P01 · FY2021 · AI

Project 4 - Mechanisms of establishing clonal dominance

$517,927
Leonard I Zon · Massachusetts General Hospital · P01 · FY2023 · HL

Regulation of Foamy Macrophage Differentiation and Survival in Atherosclerosis

$517,890
Jesse Warren Williams · University Of Minnesota · R01 · FY2024 · HL

Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas

$517,874
Rameen Beroukhim · Broad Institute, Inc. · R01 · FY2020 · CA

CRISPR-inhibition for FSHD

$517,866
Peter L Jones · University Of Nevada Reno · R01 · FY2025 · AR

CRISPR-inhibition for FSHD

$517,866
Peter L Jones · University Of Nevada Reno · R01 · FY2024 · AR

Functional Analysis of Variants Underlying T Cell Defects

$517,713
David L Wiest · University Of California, San Francisco · P01 · FY2022 · AI

Functional Analysis of Variants Underlying T Cell Defects

$517,711
David L Wiest · University Of California, San Francisco · P01 · FY2024 · AI

CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regeneration

$517,671
Zhigang He · Boston Children'S Hospital · R01 · FY2021 · EY

CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regeneration

$517,667
Zhigang He · Boston Children'S Hospital · R01 · FY2022 · EY

Modeling Type II Diabetes and hepatosteatosis Using Patient-Specific iPS Cells

$517,586
Haiming Cao · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Tumor Suppressor Protein, p53

$517,531
Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

CRISPR Tiling

$517,525
Chun-Wei David Chen · St. Jude Children'S Research Hospital · P01 · FY2025 · CA

Functional Analysis of Variants Underlying T Cell Defects

$517,472
David L Wiest · University Of California, San Francisco · P01 · FY2023 · AI

Structure, function, and evolution of the Cryptococcus MAT locus

$517,436
Joseph Heitman · Duke University · R01 · FY2020 · AI